Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities

Clinical Microbiology and Infection

Volumn 19, Issue 1, 2013, Pages

  da Costa, A C ^a   Bendit, I ^a   de Oliveira, A C S ^a   Kallas, E G ^a   Sabino, E C ^a   Sanabani, S S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coinfection; Genotypes; Human parvovirus B19; Leukaemia; Prevalence

Indexed keywords

NONSTRUCTURAL PROTEIN 1; PROTEIN VP1; PROTEIN VP2;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; BRAZIL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PARVOVIRUS B19; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS GENE;

MIRIDAE; PARVOVIRUS;

EID: 84871607024     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12058     Document Type: Article

References (53)

1. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 1983; 302: 426-429.
2. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597.
3. Agbandje M, Kajigaya S, McKenna R, Young NS, Rossmann MG. The structure of human parvovirus B19 at 8 Å resolution. Virology 1994; 203: 106-115.
4. Zhi N, Mills IP, Lu J, Wong S, Filippone C, Brown KE. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 2006; 80: 5941-5950.
5. Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 2007; 88: 428-431.
6. Shackelton LA, Holmes EC. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J Virol 2006; 80: 3666-3669.
7. Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M. B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 2003; 28: 1-13.
8. Hokynar K, Soderlund-Venermo M, Pesonen M et al. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224-228.
9. Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 2002; 301: 374-380.
10. Servant A, Laperche S, Lallemand F et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-9134.
11. Toan NL, Duechting A, Kremsner PG et al. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 2006; 87: 2941-2949.
12. Waldman M, Kopp JB. Parvovirus-B19-associated complications in renal transplant recipients. Nat Clin Pract Nephrol 2007; 3: 540-550.
13. Heegaard ED, Jensen L, Hornsleth A, Schmiegelow K. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1999; 16: 329-334.
14. Kerr JR, Barah F, Cunniffe VS et al. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. J Clin Pathol 2003; 56: 873-875.
15. Savasan S, Ozdemir O. Parvovirus B19 infection and acute lymphoblastic leukaemia. Br J Haematol 2003; 120: 168-169.
16. Sitar G, Balduini CL, Manenti L, Castello A, Balanzin D, Ascari E. Possible evolution of human parvovirus B19 infection into erythroleukemia. Haematologica 1999; 84: 957-959.
17. Zaki ME, Ashray RE. Clinical and hematological study for parvovirus B19 infection in children with acute leukemia. Int J Lab Hematol 2010; 32: 159-166.
18. Elbaz O, Shaltout A. Implication of granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) in children with acute myeloid leukaemia (AML); malignancy. Hematology 2001; 5: 383-388.
19. Sugiyama H, Inoue K, Ogawa H et al. The expression of IL-6 and its related genes in acute leukemia. Leuk Lymphoma 1996; 21: 49-52.
20. Vasconcelos GM, Christensen BC, Houseman EA et al. History of parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia. Epigenetics 2011; 6: 1436-1443.
21. Yalcin A, Serin MS, Emekdas G et al. Promoter methylation of p15(ink4b) gene is possibly associated with parvovirus B19 infection in adult acute leukemias. Int J Lab Hematol 2009; 31: 407-419.
22. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997; 53: 229-232.
23. Garcia Sde O, Kleine Neto W, da Costa AC et al. Parvovirus among patients with cytopenia of unknown origin in Brazil: a case-control study. J Clin Microbiol 2011; 49: 1578-1580.
24. Norja P, Eis-Hubinger AM, Soderlund-Venermo M, Hedman K, Simmonds P. Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol 2008; 82: 6427-6433.
25. Norja P, Hokynar K, Aaltonen LM et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 2006; 103: 7450-7453.
26. Candotti D, Danso K, Parsyan A, Dompreh A, Allain JP. Maternal-fetal transmission of human parvovirus B19 genotype 3. J Infect Dis 2006; 194: 608-611.
27. Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004; 78: 12169-12178.
28. Sanabani S, Neto WK, Pereira J, Sabino EC. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 2006; 44: 604-606.
29. Rinckel LA, Buno BR, Gierman TM, Lee DC. Discovery and analysis of a novel parvovirus B19 genotype 3 isolate in the United States. Transfusion 2009; 49: 1488-1492.
30. Soderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-1065.
31. Watzinger F, Suda M, Preuner S et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 2004; 42: 5189-5198.
32. De Renzo A, Azzi A, Zakrzewska K, Cicoira L, Notaro R, Rotoli B. Cytopenia caused by parvovirus in an adult ALL patient. Haematologica 1994; 79: 259-261.
33. El-Mahallawy HA, Mansour T, El-Din SE, Hafez M, Abd-el-Latif S. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol 2004; 26: 403-406.
34. Lindblom A, Heyman M, Gustafsson I et al. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis 2008; 46: 528-536.
35. Gustafsson I, Kaldensjo T, Lindblom A et al. Evaluation of parvovirus B19 infection in children with malignant or hematological disorders. Clin Infect Dis 2010; 50: 1426-1427.
36. Shaw PJ, Eden T, Cohen BJ. Parvovirus B19 as a cause of chronic anemia in rhabdomyosarcoma. Cancer 1993; 72: 945-949.
37. Soliman Oel S, Abd El-Aal Hegazi Hasan M, El-Ashry R, Zaghloul MH, Kora B. Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR. J Pediatr Hematol Oncol 2009; 31: 173-176.
38. Yoto Y, Kudoh T, Suzuki N, Matsunaga Y, Chiba S. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol 1993; 90: 8-12.
39. Serpa M, Sanabani SS, Dorliac-Llacer PE et al. Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission. BMC Blood Disord 2010; 10: 7.
40. Huang Y, Liu DP, Wu L et al. Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb bac carrying the human beta-globin locus. Blood Cells Mol Dis 2000; 26: 598-610.
41. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The Clustal_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-4882.
42. Hall TA. Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/nt. Nucleic Acids Symp Ser 1999; 41: 95-98.
43. Lole KS, Bollinger RC, Paranjape RS et al. Full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999; 73: 152-160.
44. Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995; 11: 1423-1425.
45. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995; 40: 249-259.
46. Kishore J, Sen M, Kumar A. A pilot study on parvovirus B19 infection in paediatric haematological malignancies. Indian J Med Res 2011; 133: 407-413.
47. Jitschin R, Peters O, Plentz A, Turowski P, Segerer H, Modrow S. Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders. Clin Microbiol Infect 2011; 17: 1336-1342.
48. Freitas RB, Melo FL, Oliveira DS et al. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon Region of Brazil. J Clin Virol 2008; 43: 60-65.
49. Keller LW, Barbosa ML, Melo FL et al. Phylogenetic analysis of a near-full-length sequence of an erythrovirus genotype 3 strain isolated in Brazil. Arch Virol 2009; 154: 1685-1687.
50. Schneider B, Hone A, Tolba RH, Fischer HP, Blumel J, Eis-Hubinger AM. Simultaneous persistence of multiple genome variants of human parvovirus B19. J Gen Virol 2008; 89: 164-176.
51. Corcioli F, Zakrzewska K, Rinieri A et al. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 2008; 80: 2005-2011.
52. Johansen JN, Christensen LS, Zakrzewska K, Carlsen K, Hornsleth A, Azzi A. Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. Virus Res 1998; 53: 215-223.
53. Nakai H, Storm TA, Kay MA. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J Virol 2000; 74: 9451-9463.